Rong Qu

Discovery of a novel third-generation EGFR inhibitor and identification of a potential combination strategy to overcome resistance

Tao Zhang, Rong Qu, Shingpan Chan et al. · Molecular Cancer · 2020 · 143 citations · Full text

Medicine, Oncology, Pharmacology +14

Baicalin attenuates in vivo and in vitro hyperglycemia-exacerbated ischemia/reperfusion injury by regulating mitochondrial function in a manner dependent on AMPK

Shanshan Li, Xiaoxu Sun, Lixing Xu et al. · European Journal of Pharmacology · 2017 · 117 citations

Life Sciences, Biochemistry, Pharmacology +15

Design, synthesis and biological evaluation of novel 6-alkenylamides substituted of 4-anilinothieno[2,3-d]pyrimidines as irreversible epidermal growth factor receptor inhibitors

Xun Ji, Ting Peng, Xu Zhang et al. · Bioorganic & Medicinal Chemistry · 2014 · 40 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +14

Design, Synthesis, and Biological Evaluation of Pyrimido[4,5-<i>d</i>]pyrimidine-2,4(1<i>H</i>,3<i>H</i>)-diones as Potent and Selective Epidermal Growth Factor Receptor (EGFR) Inhibitors against L858R/T790M Resistance Mutation

Yong‐Jia Hao, Jiankun Lyu, Rong Qu et al. · Journal of Medicinal Chemistry · 2018 · 37 citations · Full text

Medicine, Oncology, Pharmacology +13

Levo-tetrahydropalmatine Attenuates Neuron Apoptosis Induced by Cerebral Ischemia–Reperfusion Injury: Involvement of c-Abl Activation

Ruoxi Sun, Yichen Song, Shanshan Li et al. · Journal of Molecular Neuroscience · 2018 · 34 citations

Life Sciences, Neuroscience, Pharmacology +16